| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |